摘要
目的观察凯时联合倍他司汀治疗椎-基底动脉缺血性眩晕疗效。方法椎-基底动脉缺血性眩晕65例随机分为治疗组(35例)及对照组(30例);治疗组予倍他司汀40mg(加入0·9%生理盐水250mL中)联合凯时10μg(加入0·9%生理盐水250mL中)静脉滴注,1次/d,治疗10d。对照组予丹参30mL(加入0·9%生理盐水250mL中)联合脉络宁30mL(加入0·9%生理盐水250mL中)静脉滴注,1次/d,治疗10d。全部病例治疗前后均作经颅多普勒(TCD)检查。结果治疗标准按痊愈、好转,无效划分;治疗组分别为29,4,2例;总有效率为95%;对照组分别为18,4,8例,总有效率为73%(P<0·01)。结论凯时联合倍他司汀治疗椎-基底动脉缺血性眩晕的效果优于丹参联合脉络宁的治疗效果。
Objective To observe the clinical efficacy of Betahistine combined with Kaishi in treating vertigo caused by vertebro - basilar ischemic. Methods 65 patients with vertigo caused by vertebro - basilarischemic were randomly divided into the treated group （treated by combined injection of Betahistine and Kaishi） and the control group（treated by combined injection of Dansheng and Mailuoning）. All patients received the examination of TCD before and after the treatments. Results The effective rates were 95 % and 73 % in treated group and control group respectively. The difference between the two groups was significant（ P 〈 0.01 ）. Conclusion The clinical efficacy of Betahistine combined with Kaishi is better than that of Dansheng combined with Mailuoning in treating vertigo caused by vertebro - basilar ischemic.
出处
《黑龙江医学》
2006年第10期760-761,共2页
Heilongjiang Medical Journal
